Brief: NextCell In Discussions About Patients With COVID-19
March 20 (Reuters) - NextCell Pharma AB NXTCL.TE :
* NEXTCELL IN DISCUSSIONS ABOUT PATIENTS WITH COVID-19
* ON CORONAVIRUS: PARALLEL DISCUSSIONS WITH SEVERAL
HOSPITALS HAVE
BEEN INITIATED TO TREAT PATIENTS WITH COVID-19, SEVERE
RESPIRATORY TRACT INFECTION CAUSED BY NEW CORONAVIRUS, WITH STEM
CELL PRODUCT PROTRANS
Source text for Eikon: ID:nWkr79Mgnz
Further company coverage: NXTCL.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on NextCell Pharma AB
See all newsBrief: NextCell Pharma Q1 Operating Income At SEK 2.8 Million
Brief: Nextcell Pharma Q4 Operating Income SEK 1.8 Mln
Brief: Nextcell Pharma Says ProTrans Data Show Insulin Production Preservation
Brief: NextCell Board Proposes Directed Issue Of 15,000,000 Shares
Brief: Nextcell Decides To Propose Directed Share Issue Of SEK 15 Mln